Pancreatic cancer has one of the lowest survival rates of any common cancers
/Only 3% of those diagnosed expected to live 5+ years. Mainly due to the lack of symptoms and late diagnosis. Disease has already spread to other parts of the body, with minimal options for treatment. The study from Queen Mary University conducted research, which was funded by the Pancreatic Cancer Research Fund. Published in Clinical Cancer Research, scientists discovered a new biomarker (set of three proteins) which is a potential for new diagnostic test that could detect early-stage pancreatic cancer. Could be a definitive indication of whether someone has pancreatic cancer, or doesn’t
Read More